Moderna
MRNA
#1190
Rank
NZ$27.67 B
Marketcap
$71.92
Share price
-9.39%
Change (1 day)
-58.20%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: NZ$27.67 Billion

As of January 2025 Moderna has a market cap of NZ$27.67 Billion. This makes Moderna the world's 1190th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$27.67 B1.08%
2024NZ$27.38 B-54.33%
2023NZ$59.95 B-44.83%
2022NZ$108.68 B-27.91%
2021NZ$150.76 B163.14%
2020NZ$57.29 B486.18%
2019NZ$9.77 B30.58%
2018NZ$7.48 B

End of Day market cap according to different sources

On Jan 28th, 2025 the market cap of Moderna was reported to be:

NZ$30.54 Billion
by Yahoo Finance info icon info icon
NZ$30.54 Billion
by CompaniesMarketCap info icon info icon
NZ$30.54 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$0.11 B-99.59%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$439.12 B 1,486.58%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.47 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$62.42 B 125.53%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$364.90 B 1,218.43%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$4.38 B-84.16%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$642.77 B 2,222.38%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$5.25 B-81.00%๐Ÿ‡บ๐Ÿ‡ธ USA